Storz Medical

Swiss manufacturer of extracorporeal shockwave therapy (ESWT) devices. Makes both radial and focused shockwave systems used across orthopedics, sports medicine, urology, and wound care. Their MASTERPULS and DUOLITH systems are considered reference standards.

HQTagerwilen, Switzerland FOUNDED1987 REVENUENot disclosed COUNTRIES100+

Last updated: 2026-09-15

Open shortlist

Company Overview

Storz Medical is headquartered in Tagerwilen, Switzerland and was founded in 1987, which means the company has been building medical devices for 39 years. The company operates in 100+ and remains privately held. Standalone annual revenue is not separately reported (Not disclosed). Swiss manufacturer of extracorporeal shockwave therapy (ESWT) devices. Makes both radial and focused shockwave systems used across orthopedics, sports medicine, urology, and wound care. Their MASTERPULS and DUOLITH systems are considered reference standards.

The company's product portfolio centers on Focused Shockwave (ESWT), Radial Pressure Wave (RPW), Combined Shockwave, with platforms targeting 1 device category: shockwave therapy. Portfolio breadth matters for buyers because manufacturers with multiple platforms can bundle training, service contracts, and consumable agreements across devices. Single-category manufacturers typically have less negotiating flexibility, though they can offer deeper expertise in their specific domain. When evaluating Storz Medical, the right question is not whether the portfolio is wide or narrow, but whether the specific platform you need is strategically important to the company or a legacy product being phased out.

Manufacturer financial stability is a real consideration for capital equipment buyers. Storz Medical's private structure means less financial transparency, though 39 years of continuous operation is itself a meaningful signal of stability. For physicians considering a Storz Medical platform, the questions worth asking are warranty term length, parts availability commitments, software update policy, and service response times in your specific region. Manufacturers in financial distress sometimes cut these obligations first, and they rarely announce it publicly. The strongest signal of real manufacturer health is whether they are investing in new product development, acquiring complementary technology, or coasting on existing revenue.

Technology Platform

Storz Medical's core technology stack includes Focused Shockwave (ESWT), Radial Pressure Wave (RPW), Combined Shockwave. Each platform represents distinct R&D investment and targets specific clinical indications. Physicians evaluating Storz Medical devices should understand which technology drives which platform because the mechanism of action varies across the company's product lineup.

The technology portfolio is deeper than a single-platform manufacturer, which matters for practices that want to consolidate device purchases with one vendor for training, service, and consumable efficiency. Platform breadth also signals R&D commitment, though it can stretch engineering and support resources thin when the company expands into too many categories at once.

  • Focused Shockwave (ESWT)
  • Radial Pressure Wave (RPW)
  • Combined Shockwave

Product Lineup

Storz Medical currently produces the devices listed below across 1 category. Each device links to a full independent review with pricing, clinical evidence, pros and cons, and comparisons against category alternatives.

Market Position

Storz Medical competes across 1 device category, which positions the company differently in each market segment. In some categories, Storz Medical leads on installed base and brand recognition. In others, the company is the value alternative or the technology challenger. Buyers should evaluate the company category by category rather than treating it as uniformly strong or weak across its entire portfolio.

The competitive set varies by category. In shockwave therapy, Storz Medical faces a different competitive landscape than in any other segment. Some categories are dominated by 2-3 incumbents. Others are fragmenting as new entrants push on price or differentiate on clinical evidence. For physicians evaluating Storz Medical platforms, the right question is not whether the company is good or bad in general, but how well its specific platform stacks up against the named competitors in your category of interest.

Strengths and Weaknesses

Storz Medical's strengths typically include manufacturer scale, international presence (100+), and a long privately held structure. Companies with this profile usually have stronger sales infrastructure, better training programs, and more predictable parts and service support than smaller competitors. The technology portfolio (Focused Shockwave (ESWT), Radial Pressure Wave (RPW)) represents real R&D investment that smaller players can't match.

Weaknesses to weigh: any large manufacturer faces pricing pressure from value-tier competitors, distribution challenges in regions where dealer networks are thin, and the constant risk that a clinical safety signal in one product affects perception of the entire portfolio. Physicians evaluating Storz Medical should look at the specific platform they're considering rather than the parent brand. A strong manufacturer can have weak platforms in specific categories, and a struggling manufacturer can have category-leading products. Brand-level reputation is a starting point, not a substitute for platform-level diligence.

Who Should Consider Storz Medical

Storz Medical fits best for practices that value long manufacturer history and established product lines, want access to platforms across 1 category, and benefit from international support infrastructure. Practices that prioritize bundled training, multi-device service contracts, or trade-in programs across a manufacturer's portfolio also benefit from larger players like Storz Medical.

The fit is weaker for practices that prioritize the absolute lowest price, want to work with smaller manufacturers that offer more personalized service, or need niche features that only specialist competitors provide. The right manufacturer depends on what your practice values more than the manufacturer itself. Match the company to your priorities, not the other way around.

Risk Factors for Buyers

Every medical device purchase carries manufacturer risk. Storz Medical's risk profile reflects its size, history (39 years of operation), and structure (private ownership). Private-company opacity cuts both ways. You lose the quarterly financial visibility that public filings provide, but you also avoid some of the short-term pressures that push public manufacturers to cut costs or rush products to market. The best signal of health in a private manufacturer is continuous R&D investment, expanding distribution, and executive stability. Layoffs, leadership turnover, and product discontinuations are warning signs that rarely show up in press releases.

Specific risks to monitor before signing a purchase contract with Storz Medical: warranty coverage (duration, what is covered, and exclusions), parts and service response times in your region (not the national average), software update policy (are updates included in the maintenance contract or charged separately?), consumable pricing stability (have consumable prices increased by more than 5% annually over the past three years?), and ownership change risk (is the company rumored to be for sale, spinning off a division, or preparing for an IPO or acquisition?). Each of these questions has a real answer that a well-informed buyer can verify through conversations with existing Storz Medical customers in your region.

What to Negotiate with Storz Medical

Capital equipment sales reps have significant pricing flexibility that practice buyers rarely fully capture. The published list price on a Storz Medical platform is almost never the real transaction price. Most deals close at 10-20% below list for single-device purchases and 20-30% below list for multi-device bundles. End-of-quarter and end-of-year timing gives you a real pricing advantage because reps have quota pressure to close before their fiscal period closes. Trade-in programs for older devices can reduce net cost by another 10-20%, though the trade-in valuation is often where manufacturers claw back the discount.

Beyond price, the items worth negotiating with Storz Medical include: extended warranty coverage (ask for 24-36 months instead of the standard 12), applicator or accessory inclusions (always ask for additional applicators, treatment tips, or probes thrown in at no cost), consumable starter packages (enough consumables to cover 60-90 days of typical practice use), training and certification (ensure multiple providers in your practice can be trained without additional fees), marketing support (co-marketing funds, patient education materials, or launch campaign support), and trade-in credit for any existing devices you are replacing. An itemized quote can expose missing scope and contract risk. Compare like-for-like configurations and put every material promise in writing.

Storz Medical Shockwave: DUOLITH and MASTERPULS

Storz Medical shockwave systems sit near the center of many physician and clinic buying decisions because the company focuses on extracorporeal shockwave therapy. Its two flagship names are DUOLITH for focused shockwave and MASTERPULS for radial pressure wave treatment.

Storz Medical is a Swiss manufacturer of ESWT devices headquartered in Tagerwilen, Switzerland. The company serves orthopedics, sports medicine, urology, and wound care, with systems that have become familiar fixtures in practices where shockwave is part of the treatment plan rather than a novelty sitting in the corner.

Storz Medical Company Profile

Storz Medical was founded in 1987 in Tagerwilen, Switzerland, and has 39 years of continuous operation Device Pulse Storz Medical profile. It remains privately held, which limits public financial detail but keeps the company identified with a narrow, durable specialty: shockwave therapy devices.

That focus is the point. Some medical-device manufacturers spread themselves across imaging, surgical tools, rehab equipment, and disposable supplies. Storz Medical built its identity around shockwave. For a buyer, that creates a cleaner question: does the company's clinical depth, installed base, and service footprint fit the care you plan to deliver?

Storz Medical operates in 100+ countries Device Pulse Storz Medical profile. That reach matters most when a practice is considering long-term parts access, handpiece support, training, and resale familiarity. A system can look great in a demonstration and become a headache when service is slow or consumables are hard to source.

DUOLITH and MASTERPULS are often treated as reference standards in their respective categories. That reputation comes with a practical benefit: patients, referring clinicians, and experienced operators may already know the names. It also comes with a practical cost. Brand familiarity does not answer whether focused energy or radial pressure waves fit the conditions your clinic sees.

For an overview of the broader market, see the shockwave therapy category. It helps put Storz beside other systems without treating every device as interchangeable.

Focused vs Radial Shockwave: How the Storz Lineup Splits

The Storz lineup divides around two treatment approaches. DUOLITH systems use focused shockwave technology. MASTERPULS systems use radial pressure wave technology.

Focused shockwave directs acoustic energy toward a selected tissue depth. It is usually the conversation when a clinician wants to treat a more defined target and build a protocol around focused ESWT. The DUOLITH review covers the platform in more detail, including the questions worth asking before committing to a focused system.

Radial pressure wave treatment delivers energy differently. Its clinical feel, workflow, and intended use differ from focused shockwave, even when both systems sit under the broad "shockwave" label. MASTERPULS has a place in practices where radial treatment aligns with the musculoskeletal conditions, operator preferences, and patient flow already on the schedule.

That distinction gets blurred in sales conversations because "shockwave" is easier to say than "what kind of energy do you need, at what target, for which clinical protocols?" The latter question is the one that decides whether the device earns its floor space.

A sports medicine practice treating a broad mix of soft-tissue complaints may evaluate radial treatment differently from a urology practice considering focused therapy. Orthopedics may have its own preferences based on diagnosis mix and referral patterns. Wound care adds another layer because the clinical environment, staffing, and documentation demands are different again.

Storz makes both approaches available, which gives buyers a path to stay within one manufacturer while selecting technology for the work. That can simplify training and service relationships. It should not simplify the clinical decision into a logo choice.

Ask the sales representative to show how each platform fits your common treatment protocols. Ask what the operator does between patients, what consumables are required, how handpieces are maintained, and which settings are controlled during a standard treatment. The answers will tell you more than a polished product brochure.

DUOLITH and MASTERPULS Pricing

The price gap between focused and radial systems reflects more than branding. It reflects different technology, configuration, clinical use, and capital commitment.

The DUOLITH SD1 focused shockwave system runs $60,000-$120,000 Device Pulse Storz Medical profile. The MASTERPULS MP200 radial shockwave system runs $35,000-$70,000 Device Pulse Storz Medical profile.

Storz deviceTechnology typePrice range
DUOLITH SD1Focused shockwave$60,000-$120,000
MASTERPULS MP200Radial pressure wave$35,000-$70,000

Those ranges are starting points for capital planning, not a complete purchase quote. Configuration, included accessories, warranty terms, training, service arrangements, and local dealer support can change what a practice pays and what it receives.

A cheaper system can become expensive when downtime disrupts a treatment schedule. A more expensive system can be hard to justify if the practice lacks a clear protocol, referral base, or cash-pay plan. The money question belongs beside the clinical question.

The DUOLITH cost breakdown is useful if focused shockwave is the likely fit. It gives the price conversation somewhere more concrete to go than "premium equipment costs more."

Buyers should also separate acquisition price from operating reality. Find out whether the quoted package includes installation, training, handpieces, software access, preventive maintenance, and replacement parts. Ask what happens when a handpiece fails. Ask who services the unit locally. Ask how long the practice can expect to wait.

Warranty terms deserve the same scrutiny. A broad warranty statement means little unless it identifies what is covered, who performs the repair, and what happens to scheduled patients while the system is unavailable. The attractive quote is rarely the whole deal.

Clinical Positioning for DUOLITH and MASTERPULS

DUOLITH is the focused side of the Storz portfolio. It will draw attention from clinics looking for focused ESWT and from clinicians who already have protocols built around that modality. In some practices, the platform supports a more specialized service line. In others, it becomes part of a larger orthopedic, sports medicine, or urology offering.

MASTERPULS is the radial side. It may fit clinics that want radial pressure wave treatment integrated into a busy musculoskeletal workflow. Physical therapy practices often care as much about handpiece ergonomics, room turnover, and staff training as they do about the device's headline specifications. Physicians should care too. The person operating the system has to live with it every day.

Neither platform is a universal answer. A clinic can be clinically sophisticated and still buy the wrong modality for its patient mix. That mistake usually starts with a vague purchase goal: "we need shockwave." A better goal names the conditions treated, the clinician responsible, the intended payment model, and the expected role of the device in the practice.

Storz has an advantage when a buyer wants a manufacturer that specializes in this category. The company's systems carry recognition, and its Swiss identity plays well with buyers who associate medical equipment from Switzerland with precision engineering. Those are valid considerations. They are not substitutes for reviewing the actual device, contract, and clinical use case.

Who Should Buy a Storz Medical System

Storz Medical makes the most sense for a practice that has already decided shockwave belongs in its care model and needs to choose between focused and radial technology.

Physicians with a defined musculoskeletal, orthopedic, sports medicine, or urology use case may value the company's category focus. Clinics building a new service line may also prefer a manufacturer whose core reputation is tied to shockwave rather than an unrelated equipment catalog.

Physical therapy practices should look closely at staffing. Who will operate the system? How will patients be scheduled? Which provider explains the treatment plan? How does the practice handle candidacy, consent, documentation, and follow-up? A device purchase can expose weak workflow fast.

The buyer who benefits least is the one searching for a generic revenue device without a clinical plan. Shockwave may have cash-pay appeal, but a treatment room does not fill itself. Referrals, patient education, clinician confidence, and consistent protocols determine whether the purchase becomes a durable service line or an expensive piece of furniture.

Service coverage can decide the outcome. Before signing, ask about warranty coverage, parts availability, software updates, and service response times. Ask whether repairs are handled locally, whether loaner equipment is available, and whether training is included for future staff rather than only the first operator.

You should also ask the dealer to describe the installed configuration in plain language. Which handpieces are included? What treatments does the package support? What items are excluded? Where do consumable costs appear? A quote should make those answers easy to find.

Storz wins when the buyer wants a well-known shockwave specialist and has matched the platform to a specific clinical workflow. The company loses ground when a practice pays for reputation without doing the harder work of selecting the right modality.

Frequently Asked Questions

Where is Storz Medical headquartered?

Storz Medical is headquartered in Tagerwilen, Switzerland. The company was founded in 1987 and currently operates in 100+. Standalone annual revenue is not separately reported (Not disclosed). The company has a private financial structure.

What devices does Storz Medical make?

Storz Medical produces devices across 1 category: shockwave therapy. Key technologies include Focused Shockwave (ESWT), Radial Pressure Wave (RPW), Combined Shockwave. The current US-market device lineup includes DUOLITH SD1, MASTERPULS MP200.

Is Storz Medical financially stable?

Storz Medical does not separately report standalone annual revenue (Not disclosed). As a private company, financial details are limited, though the company has operated continuously since 1987. For capital equipment buyers, manufacturer financial stability matters because it affects warranty support, parts availability, and long-term software updates. Always verify the most recent financial position before signing a multi-year service contract.

How does Storz Medical compare to competitors?

Storz Medical competes across 1 device category, with different competitive positions in each. In some categories the company leads on installed base; in others it's a value alternative or technology challenger. The competitive set should be evaluated category by category. Physicians considering a specific Storz Medical platform should compare it directly against the other devices in that category, not against the manufacturer as a whole.

Where can I buy Storz Medical devices?

Storz Medical sells direct in some markets and through authorized dealers in others. Dealer presence and direct sales support vary by US region. For practices in major metro areas, multiple dealer relationships are typical. For practices in smaller markets, dealer access can be a limiting factor on training and service support. Verify dealer presence in your specific region before signing a purchase contract.

Does Storz Medical offer financing or leasing?

Most major device manufacturers including Storz Medical offer financing partnerships through third-party lenders, leasing arrangements with end-of-term buyout options, and trade-in programs for older devices. Terms vary by credit profile and total purchase size. Financing rates for capital medical equipment typically run 6-9% APR over five-year terms. Practices should always compare manufacturer financing against independent equipment lenders to ensure competitive rates.

What is Storz Medical known for in 2026?

As of April 2026, Storz Medical is known primarily for Focused Shockwave (ESWT), Radial Pressure Wave (RPW) technologies and platforms across 1 device category. The company's market position varies by category. In some segments Storz Medical leads on installed base or clinical evidence depth. In others the company competes as a value alternative or technology challenger. The 39-year operating history (since 1987) gives the company an established reputation in the medical device buyer community, though buyer perception varies meaningfully by specialty and region.

Is Storz Medical a good company to buy from in 2026?

Whether Storz Medical is a good company to buy from depends on your specific platform need, regional dealer support, and total cost of ownership analysis. Strengths typically include Focused Shockwave (ESWT), the 39-year operating track record, and platform integration across the company's portfolio. Considerations: verify recent financial trajectory (private company financial transparency limited), confirm regional dealer presence and service capabilities, and check FDA MAUDE reports for recent adverse event signals. Compare against direct competitors in the specific category before committing.

What is Storz Medical's market position vs competitors in 2026?

Storz Medical's market position in 2026 varies by device category. The company competes across 1 device category (shockwave therapy), with different competitive positions in each. In some categories Storz Medical leads on installed base or technology innovation. In others the company is a value alternative competing on price or specific features. To evaluate market position for the specific platform you are considering, request peer references in your specialty and region, check installed base data from industry publications, and compare clinical evidence depth across the competitive set.

What's the latest news from Storz Medical in 2026?

Recent Storz Medical updates relevant to capital equipment buyers in 2026 include periodic business updates, FDA labeling changes, software releases for installed devices, new applicator launches, and clinical evidence publications. Storz Medical company press releases and trade press coverage are the most reliable sources for the latest operational and financial updates. Buyers evaluating multi-year service contracts should always check the most recent updates before committing because manufacturer trajectory affects long-term support quality.